$25.72
-0.02-0.08%
At close: -
$25.75
0.030.12%
After Hours: 7:38 PM EDT
Comments
Loading...
Catalyst Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:CPRX | Benzinga
Catalyst Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$0.440
Quarterly Revenue Estimate
$128.58M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$491.73M
Analyze the earnings history of Catalyst Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals | $0.38 | $0.44 | — | — | $98.51M | $128.58M | — | — | 05/07/2025 | Get Alert |
| CPRX | Catalyst Pharmaceuticals | $0.53 | $0.55 | $0.70 | 27.27% | $110.57M | $134.20M | $141.81M | 5.67% | 02/26/2025 | Get Alert |
| CPRX | Catalyst Pharmaceuticals | $0.49 | $0.30 | $0.57 | 90.00% | $102.69M | $123.42M | $128.69M | 4.27% | 11/06/2024 | Get Alert |
| CPRX | Catalyst Pharmaceuticals | $0.53 | $0.26 | $0.56 | 115.38% | $99.58M | $111.96M | $122.71M | 9.60% | 08/07/2024 | Get Alert |
| CPRX | Catalyst Pharmaceuticals | $0.41 | $0.17 | $0.38 | 123.53% | $85.37M | $98.13M | $98.51M | 0.39% | 05/08/2024 | Get Alert |
| CPRX | Catalyst Pharmaceuticals | $0.31 | $0.26 | $0.53 | 103.85% | $60.76M | $106.12M | $110.57M | — | 02/28/2024 | Get Alert |
| CPRX | Catalyst Pharmaceuticals | $0.26 | $0.44 | $0.49 | 11.36% | $57.24M | $100.38M | $102.69M | 2.30% | 11/08/2023 | Get Alert |
| CPRX | Catalyst Pharmaceuticals | $0.28 | $0.42 | $0.53 | 26.19% | $53.11M | $92.73M | $99.58M | 7.39% | 08/09/2023 | Get Alert |
| CPRX | Catalyst Pharmaceuticals | $0.12 | $0.32 | $0.41 | 28.12% | $43.09M | $81.62M | $85.37M | 4.59% | 05/10/2023 | Get Alert |
| CPRX | Catalyst Pharmaceuticals | $0.09 | $0.21 | $0.31 | 47.62% | $38.31M | $58.09M | $60.76M | 4.59% | 03/15/2023 | Get Alert |
| CPRX | Catalyst Pharmaceuticals | $0.10 | $0.19 | $0.26 | 36.84% | $35.95M | $53.62M | $57.24M | 6.76% | 11/09/2022 | Get Alert |
| CPRX | Catalyst Pharmaceuticals | $0.11 | $0.17 | $0.28 | 64.71% | $36.37M | $49.21M | $53.11M | 7.93% | 08/09/2022 | Get Alert |
| CPRX | Catalyst Pharmaceuticals | $0.07 | $0.14 | $0.12 | -14.29% | $30.20M | $42.75M | $43.09M | 0.79% | 05/10/2022 | Get Alert |
| CPRX | Catalyst Pharmaceuticals | $0.11 | $0.12 | $0.09 | -25.00% | $31.02M | $38.19M | $38.31M | 0.31% | 03/16/2022 | Get Alert |
| CPRX | Catalyst Pharmaceuticals | $0.13 | $0.10 | $0.10 | 0.00% | $29.32M | $34.59M | $35.95M | 3.94% | 11/09/2021 | Get Alert |
| CPRX | Catalyst Pharmaceuticals | $0.09 | $0.09 | $0.11 | 22.22% | $29.61M | $31.51M | $36.37M | 15.41% | 08/09/2021 | Get Alert |
| CPRX | Catalyst Pharmaceuticals | $0.10 | $0.09 | $0.07 | -22.22% | $29.14M | $32.10M | $30.20M | -5.90% | 05/10/2021 | Get Alert |
| CPRX | Catalyst Pharmaceuticals | $0.07 | $0.09 | $0.11 | 22.22% | $30.12M | $30.35M | $31.02M | 2.19% | 03/15/2021 | Get Alert |
| CPRX | Catalyst Pharmaceuticals | $0.13 | $0.10 | $0.13 | 30.00% | $30.90M | $31.49M | $29.32M | -6.90% | 11/09/2020 | Get Alert |
| CPRX | Catalyst Pharmaceuticals | $0.10 | $0.08 | $0.09 | 12.50% | $28.84M | $29.48M | $29.61M | 0.42% | 08/10/2020 | Get Alert |
| CPRX | Catalyst Pharmaceuticals | -$0.01 | $0.09 | $0.10 | 11.11% | $12.45M | $31.46M | $29.14M | -7.39% | 05/11/2020 | Get Alert |
Catalyst Pharmaceuticals (CPRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-26 | $0.70 | $0.55 | 27.3 % |
| Q3 | 2024-11-06 | $0.57 | $0.30 | 90.0 % |
| Q2 | 2024-08-07 | $0.56 | $0.26 | 115.4 % |
| Q1 | 2024-05-08 | $0.38 | $0.17 | 123.5 % |
Catalyst Pharmaceuticals (CPRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-26 | $141.81M | $134.20M | 5.67 % |
| Q3 | 2024-11-06 | $128.70M | $123.42M | 4.27 % |
| Q2 | 2024-08-07 | $122.71M | $111.96M | 9.60 % |
| Q1 | 2024-05-08 | $98.51M | $98.13M | 0.39 % |
FAQ
When is Catalyst Pharmaceuticals (NASDAQ:CPRX) reporting earnings?
Catalyst Pharmaceuticals (CPRX) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on February 26, 2025 for Q4.
What were the latest earnings per share (EPS) for Catalyst Pharmaceuticals (NASDAQ:CPRX)?
The Actual EPS was $0.70, which beat the estimate of $0.55.
What were Catalyst Pharmaceuticals’s (NASDAQ:CPRX) revenues?
The Actual Revenue was $141.8M, which beat the estimate of $134.2M.
Browse earnings estimates, EPS, and revenue on all stocks.